Bellevue Group Ag Olink Holding Ab (Publ) Transaction History

Bellevue Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$14.45 - $20.34 $323,217 - $454,965	-22,368 Reduced 9.33%	217,256 $3.2 Million
Q1 2023 May 15, 2023	SELL	$19.34 - $24.11 $223,589 - $278,735	-11,561 Reduced 4.6%	239,624 $5.4 Million
Q4 2022 Feb 14, 2023	BUY	$12.64 - $25.52 $261,180 - $527,319	20,663 Added 8.96%	251,185 $6.38 Million
Q3 2022 Nov 14, 2022	SELL	$12.14 - $18.42 $57,677 - $87,513	-4,751 Reduced 2.02%	230,522 $2.8 Million
Q4 2021 Feb 10, 2022	BUY	$18.0 - $34.82 $679,428 - $1.31 Million	37,746 Added 19.11%	235,273 $4.28 Million

Q2 2021 Aug 12, 2021	BUY	$26.65 - $39.47 $1.21 Million - $1.79 Million	45,390 Added 29.83%	197,527 $6.8 Million
Q1 2021 May 12, 2021	BUY	$31.9 - $36.0 $4.85 Million - $5.48 Million	152,137 New	152,137 $5.48 Million

38.1M

52.2K

134K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Market Cap $3.1B
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.